ORGENESIS
Live / Allowed — Third extension granted (statement of use) (as of 27 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jan 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98373717
- Mark type
- Word mark
- Filed
- 24 Jan 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders
Owner
- Orgenesis Inc., Germantown, MD, US
- Orgenesis Inc., Germantown, MD, US
Prosecution history
- 10 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 May 2026 — SOU EXTENSION 3 GRANTED
- 27 May 2026 — SOU EXTENSION 3 FILED
- 27 May 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 02 Dec 2025 — SOU EXTENSION 2 FILED
- 18 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 18 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 18 Feb 2026 — PETITION TO REVIVE-GRANTED
- 18 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED